HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Feiring, A. J. Articles by Lade, S. Search for Related Content PubMed PubMed Citation Articles by Feiring, A. J. Articles by Lade, S.

CLINICAL RESEARCH: INTERVENTIONAL CARDIOLOGY

Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication

Early and one-year outcomes

Columbia-St. Mary's Medical Center, Milwaukee, Wisconsin

Manuscript received May 25, 2004; revised manuscript received August 26, 2004, accepted September 14, 2004.

^* Reprint requests and correspondence: Dr. Andrew J. Feiring, Director Cardiac and Vascular Intervention, Columbia-St. Mary's Medical Center, Suite 208, 2015 East Newport Avenue, Milwaukee, Wisconsin 53211 (Email: afeiring{at}execpc.com).

OBJECTIVES: The objective of this study was an investigation of the safety and efficacy of primary below-knee stent-supported angioplasty (BKSSA) for restoring straight inline arterial flow in patients with critical limb ischemia (CLI) or lifestyle-limiting claudication (LLC).

BACKGROUND: Surgical tibial bypass for CLI and severe LLC is associated with significant morbidity, mortality, and graft failure, whereas percutaneous angioplasty is suboptimal.

METHODS: Below-knee stent-supported angioplasty was attempted in 82 patients (92 limbs) with either CLI (68%) or severe LLC (32%). Patients received daily aspirin, thienopyridine, and glycoprotein IIb/IIIa agents during the procedure. One-month major adverse events (MAEs) were defined as death, myocardial infarction, major unplanned amputation, need for surgical revascularization, or major bleeding. Clinical success was defined as improved resting ankle brachial index by 0.10, relief of resting pain, healing of ulceration or amputation, and improvement of claudication.

RESULTS: Mean age of patients was 74 ± 17 years. In 86 limbs, straight inline flow was restored to at least one tibial vessel. Technical success was 94% for de novo lesions and there were no MAEs. Ankle brachial indexes increased for all groups (CLI = 0.32 ± 0.13 to 0.9 ± 0.14 and LLC = 0.65 ± 0.09 to 0.95 ± 0.12; p 0.0001, pre vs. post). Relief of rest pain and healing of ulcerations and amputations were seen in 96% (47 of 49) of patients with CLI who underwent successful intervention.

CONCLUSIONS: Below-knee stent-supported angioplasty for CLI and LLC improves ankle brachial indexes comparable to tibial bypass, heals amputations and ulcerations, relieves rest pain, and improves ambulation. Because BKSSA is associated with minimal MAE, it may hold promise as an alternative therapy for patients with CLI and LLC.

Abbreviations and Acronyms   ABI = ankle brachial index   BKSSA = below-knee stent-supported angioplasty   CLI = critical limb ischemia   DES = drug-eluting stent   LLC = lifestyle-limiting claudication   MAE = major adverse events   MI = myocardial infarction   PTA = percutaneous transluminal angioplasty

This article has been cited by other articles:

				S. A Arain and C. J White Endovascular therapy for critical limb ischemia Vascular Medicine, August 1, 2008; 13(3): 267 - 279. [Abstract] [PDF]

				A. J. Feiring Footnotes on Critical Limb Ischemia J. Am. Coll. Cardiol., May 20, 2008; 51(20): 1975 - 1976. [Full Text] [PDF]

				J. H. Rogers and J. R. Laird Overview of New Technologies for Lower Extremity Revascularization Circulation, October 30, 2007; 116(18): 2072 - 2085. [Abstract] [Full Text] [PDF]

				G. Tepe, C. Hopfenzitz, K. Dietz, J. Wiskirchen, S. Heller, K. Ouriel, G. Ziemer, C. D. Claussen, and S. H. Duda Peripheral Arteries: Treatment with Antibodies of Platelet Receptors and Reteplase for Thrombolysis--APART Trial Radiology, June 1, 2006; 239(3): 892 - 900. [Abstract] [Full Text] [PDF]

				B. E. Muhs, P. J. Gagne, T. Maldonado, and P. Sheehan Minimally invasive revascularization strategies for chronic lower limb ischemia. International Journal of Lower Extremity Wounds, March 1, 2006; 5(1): 35 - 39. [Abstract] [PDF]